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Cissus incisa is used in traditional Mexican medicine to treat certain ailments, infectious or cancerous diseases.
Excepting for our previous research, this species had no scientific reports validating its traditional use. In this
study, we evaluated the antibacterial and cytotoxic properties of the sphingolipids and others phytocompounds
isolated from C. incisa leaves to increase the scientific knowledge of the Mexican flora. The antibacterial activity
was evaluated against Gram-positive and Gram-negative bacteria by the Microdilution method. Meanwhile, the
cytotoxic potential was determined on six human cancer cells: PC3, Hep3B, HepG2, MCF7, A549, and HeLa; using
an aqueous solution cell proliferation assay kit. A cell line of immortalized human hepatocytes (IHH) was included
as a control of non-cancerous cells. Selectivity index (SI) was determined only against the hepatocellular carci-
noma cell lines. The phytochemical investigation of C. incisa leaves resulted in the isolation and characterization
of five compounds: 2-(20-hydroxydecanoyl amino)-1,3,4-hexadecanotriol-8-ene (1), 2,3-dihydroxypropyl tetra-
cosanoate (2), β-sitosterol-D-glucopyranoside (3), α-amyrin-3-O-β-D-glucopyranoside (4), and a mixture of ce-
rebrosides (5). Until now, this is the first report of the sphingolipids (1), (5-IV) and (5-V). Only the compound (4)
and cerebrosides (5) exhibited antibacterial activity reaching a MIC value of 100 μg/mL against Pseudomonas
aeruginosa resistant to carbapenems. While, the acetylated derivate of (3), compound (3Ac) showed the best
cytotoxic result against PC3 (IC50 ¼ 43  4 μg/mL) and Hep3B (IC50 ¼ 49.0  4 μg/mL) cancer cell lines.
Likewise, (3Ac) achieved better SI values on HepG2 and Hep3B cell lines. This research reveals the importance of
study medicinal plants, to identify bioactive molecules as sources of potential drugs. The presence of these
compounds allows us to justify the use of this plant in traditional Mexican medicine.lipids and other phytocompounds isolated from Cissus incisa leaves, Spectral data of new sphingolipids and other
Data in Brief, In Press.
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The spread of antibiotic-resistant bacteria represents a substantial
threat to morbidity and mortality worldwide. Multidrug-resistant in-
fections are being considered by World Health Organization (WHO) as a
global priority to develop new drugs (Tacconelli et al., 2018). Cancer
constitutes another serious problem of public health in the world. It is a
dangerous disease-causing high mortality among the human population.
Historically, plants have provided a good source of anti-infective and
anti-cancer agents. Some active ingredients in these medicines have been
isolated from plants used by various cultures for the treatment of diseases
with cancerous symptoms and the treatment of infections. For this
reason, ethnomedical reports are considered of great value in drug dis-
covery (Vega-Avila et al., 2006; Rossiter et al., 2017; Gezici and
S¸ekeroglu, 2019).
The genus Cissus, which belongs to the Vitaceae family, comprises
about 350 species of all continents. Many cultures have used locally
available species belonging to this genus to treat several medical prob-
lems (Fernandes and Banu, 2012). Previous investigations point to
antimicrobial and anticancer properties of some Cissus extracts: C.
quadrangularis (whole plant) (Ndhlovu and Masika, 2017), C. cornifolia
(leaves and roots) (Chipiti et al., 2017), C. quadrangularis (aerial parts)
(Kumar et al., 2017), C. quadrangularis (stems) (Fouche et al., 2016).
Cissus incisa (Nutt.) Des Moul. ex S. Watson, commonly known as
“hierba del buey” is a plant native to the southern United States and
adjacent parts of northern Mexico. It is fast-growing, climbing, with
attractive green toothed leaves. Its flowers are white in summer, giving
rise to blackish fruits in autumn (Learn2Grow, 2016; SEINet, 2019).
According to traditional Mexican medicine, its leaves are used to treat
skin infections, abscesses, and tumors (Alvarado Vazquez et al., 2010).
Excepting for our investigation, this species had no scientific reports and
its traditional use was not validating.
Currently, many researchers are interested in giving scientific
authentication and explanation to the biological activities of plants used
in traditional medicine throughout the world. Traditional uses of C. incisa
motivated our effort to investigate their phytochemistry and their phar-
macological activities. Formerly, we have determined the antimicrobial
properties of the chloroform/methanol, and hexane extracts of C. incisa
leaves (Nocedo-Mena et al., 2020) and some active phytocompounds,
including new antibacterial ceramides (Nocedo-Mena et al., Unpublished
results). Ceramides and cerebrosides are sphingolipids that represent a
significant proportion of the lipids in higher plants. Some studies suggest
that they constitute up to 10 % of plant lipids. Novel plant lipid structures
are still being discovered, and over two hundred have been identified in
various species to date. The wide range of sphingolipid structures facil-
itates their function in a variety of cellular processes. This enables these
molecules to be involved in diverse activities as the structural integrity of
the membranes, membrane domain formation, and the response of plants
to hypoxia and pathogen attack (Michaelson et al., 2016).
The present study aimed to determine the antibacterial and cytotoxic
properties of the sphingolipids and other phytocompounds. Five natural
products were isolated and characterized: 2-(20-hydroxydecanoyl
amino)-1,3,4-hexadecanotriol-8-ene (1), 2,3-dihydroxypropyl tetracosa-
noate (2), β-sitosterol-D-glucopyranoside (3), α-amyrin-3-O-β-D-gluco-
pyranoside (4) and amixture of cerebrosides (5). This is the first report of
the sphingolipids (1), (5-IV) and (5-V). The structural elucidation was
performed by a combination of spectroscopic analyses, including 1D and
2D NMR, UHPLC-QToF-MS and chemical reactions. Additionally, acety-
lated derivatives of the natural compounds were obtained.
The antibacterial potential of sphingolipids and the other compounds
was evaluated, also their cytotoxic properties. Only (4) and (5) exhibited
antibacterial activity with MIC values of 100 μg/mL each, against
P. aeruginosa resistant to carbapenems. While, the β-sitosteryl β-D-tet-
raacetyl glucopyranoside (3Ac) showed the best cytotoxic result against
PC3 (IC50 ¼ 43  4 μg/mL) and Hep3B (IC50 ¼ 49.0  4 μg/mL) cancer
cell lines. Values obtained for Selectivity Index (SI) on hepatocellular2carcinoma lines, revealed potentialities of the compounds for being used
selectively to treat this type of cancer.
2. Materials and methods
2.1. General experimental procedures
Melting points were measured with a Thermo Scientific P12144Q
Fisher-Johns Melting Point apparatus. Column chromatography (CC) was
conducted with silica gel (EMD Chemicals Inc. brand, Sigma Aldrich).
Thin-Layer Chromatography (TLC) was carried out on 0.2 mm thick silica
gel plates (Merck 60 F254). Solvent systems used in TLC were: CHCl3/
MeOH, Hex/EtOAc, CHCl3/Acetone, CHCl3/MeOH/CH3COOH. The
chemicals and reagents were acquired from Sigma-Aldrich (St. Louis,
Missouri, USA) or Baker (Baker, Phillipsburg, New Jersey, USA). Spots
were detected by TLC using UV lamp (Spectroline brand) and solutions of
ceric sulfate in sulfuric acid with subsequent heating. IR spectra were
recorded with a Bruker ALPHA ATR-FTIR spectrometer. NMR spectra
were obtained on a Bruker NMR 400 spectrometer operated at 400 MHz
(1H) and 100MHz (13C) using deuterated solvents with tetramethylsilane
(TMS) as internal reference.
2.1.1. GC-MS analysis
Samples were processed on an Agilent Model 6890 Gas Chromato-
graph (Agilent Technologies, Santa Clara, CA, USA) with a Selective Mass
Detector (Agilent Model 5973N) operated in the electronic impact mode
at 70 eV. The technique was developed with the following conditions:
column HP-5MS (30 m  0.250 mm X 0.25 μm), the carrier gas was
helium (1 mL/min constant flow), the initial oven temperature was 50
C, rising 2 C/min to 285 C for 35 min (final time). The retention index
of compounds was recorded with standard n-hydrocarbon calibration
mixture (C10–C40, Honeywell Fluka, Germany) using 2.64 AMDIS soft-
ware. The results were given with reference to the NIST library database
version 1.7a.
2.1.2. UHPLC-QToF-MS analysis
Ultra-High Performance Liquid Chromatography (UHPLC) was car-
ried out using a Waters ACQUITY UPLC™ system (Milford, MA, USA).
A reverse phase column (Acquity UPLC C18 CSH, 100  2.1 mm, 1.7
μm) and a pre-column (Acquity UPLC C18 CSH 1.7 μm VanGuardTM)
were used at 65 C. The samples were dissolved in CHCl3/MeOH (1:2,
v/v) at 25 μg/mL. Mobile phases consisted of acetonitrile and water
(40:60, v/v) with 10 mM ammonium formate and 0.1% formic acid
(phase A), and acetonitrile and isopropanol (10:90, v/v) with 10 mM
ammonium formate and 0.1% formic acid (phase B). Flow rate was 500
μL/min and injection volume was 7.5 μL. The gradient used for the
lipid profiling was established as follows: initial conditions were 40 %
B, raised to 43 % B over 2.0 min and to 50 % B over 0.10 min more.
During the next 9.90 min it was raised to 54 % B and in 0.1 min more
to 70 % B. In 5.90 min, it was raised to 100 % B and held at 100 % B
until 19.0 min, decreased to 40 % B over the next 0.1 min, and held at
40 % B 1.90 min for re-equilibration of the system prior to the next
injection.
All mass spectrometry data was acquired on a SYNAPT G2 HDMS,
with a quadrupole time of flight (Q-ToF) configuration (Waters, Milford,
MA, USA), equipped with an Electrospray Ionization source (ESI) oper-
ated in positive mode. The capillary voltage was set to 1 kV. Nitrogen was
used as desolvation and cone gas, at flow rates of 1000 L/h and 10 L/h,
respectively. The source temperature was 120 C and the desolvation
temperature was 500 C. A leucine-enkephalin solution (2 ng/μL) was
used for lock-mass correction. The reference internal standard was
introduced into the lockmass sprayer at a constant flow rate of 10 μL/min
with an external pump. Data acquisition took place over the mass range
50–1200 u in resolution mode (FWHM20.000) with a scan time of 0.3 s
and an inter-scan delay of 0.024 s. The cone voltage was set to 40 V. The
mass spectrometer was operated in the continuumMSE acquisition mode.
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Leaves from C. incisa were collected in Rayones, Nuevo Leon, Mexico
(Latitude: 25.0167, Longitude: -100.05, Altitude: 900 m), in October
2016. The identification was made by the biologist Mauricio Gonzalez
Ferrara. The collected species was deposited in the herbarium of the
Faculty of Biology of the Universidad Autonoma de Nuevo Leon under
the register number 027499.
2.3. Extraction and isolation
The leaves were dried at room temperature for 2 weeks, milled in a
knife mill until obtaining 809 g of dried and grounded plant material. The
powder was extracted four times with CHCl3/MeOH 1:1 (7 L) at room
temperature and then filtered. The filtrate was concentrated under vac-
uum to afford the crude CHCl3/MeOH extract (84 g), subjected to suc-
cessive CCs, eluted with Hex/EtOAc/MeOH gradients until twenty-four
pooled fractions (fr. A to fr. X) were obtained. Fr. E (Hex/EtOAc 85:15; 4
g) was analyzed by CC with Hex/EtOAc gradients until obtained 73 sub-
fractions. Sub-fraction 37–46 (Hex/EtOAc 80:20; 16.2 mg) was then
purified by another CC (Hex/CH2Cl2/Acetone) getting 138 sub-fractions.
From this last CC, sub-fraction 121–126 (CH2Cl2/Acetone 96:4) yielded
12.1 mg (0.0015%) of a white solid (1). Fr. O (Hex/EtOAc 70:30; 1.1 g)
was subjected to a silica gel CC using CH2Cl2/EtOAc gradient, giving 110
sub-fractions. From sub-fraction 61–75 (CH2Cl2/EtOAc 80:20) precipi-
tated a solid. This solid was purified by several re-crystallizations with
CH2Cl2/EtOAc 80:20 until 18.9 mg (0.0023%) of a white solid (2) was
obtained. Fr. T (EtOAc/MeOH 90:10; 2.78 g) was chromatographed using
CHCl3/MeOH gradient until 72 sub-fractions were acquired. From these,
the sub-fraction 19–27 (solid, 4.12 g, CHCl3/MeOH 80:20) was purified
on a silica gel CCwith CHCl3/MeOH gradient, giving 102 sub-fractions. A
yellowish-white solid precipitated from sub-fraction 79–90 (CHCl3/
MeOH 82:18), which was repeatedly washed with acetone, yielding 82
mg (0.01%) of a white solid (3). Meanwhile, from sub-fraction 28–47
(CHCl3/MeOH 80:20; 35.9 mg) a solid was obtained. It was washed with
acetone and purified by recrystallization with chloroform obtaining 32.7
mg (0.004%) of the compound (4). Fr. S and fr. U were joined because of
chromatographic similarity giving 3.685 g of the mixture, which was
subjected to CC using CH2Cl2/MeOH gradient until obtained 114 sub-
fractions. From the sub-fractions 90–99 (CH2Cl2/MeOH 80:20) was ob-
tained a precipitated, which was repeatedly washed with acetone,
yielding 294 mg (0.036%) of a brown solid (5). The purity of the natural
products obtained was determined by the following criteria: chromato-
graphic homogeneity, melting points and two-dimensional
chromatography.
2-(20-hydroxydecanoyl amino)-1,3,4-hexadecanotriol-8-ene (1). White
solid, mp:123–125 C, HRMS-ESI (positive ionization mode) m/z:
475.3250 [M þ H2O]þ, 457.3250 [M]þ (C26H51NO5, calc. 457.3767). 1H
NMR (400 MHz, CDCl3) δ (ppm): 0.90 (t, J ¼ 6.66 Hz, 6H, CH3), 1.28
(brs, 22H, CH2), 1.62 (m, 6H, CH2), 1.99 (m, 2H, H-10), 2.05 (m, 2H, H-
7), 3.65 (m, 2H, H-3, H-4), 3.82 (m, 1H, H-1β), 3.97 (m, 3H, H-20, H-1α),
4.17 (m, 4H, H-2, OH), 5.42 (m, 2H, H-8, H-9), 7.02 (m, 1H, NH). 13C
NMR (100 MHz, CDCl3) δ (ppm): 14.13 (2CH3), 22.70 (CH2), 24.18
(CH2), 24.96 (CH2), 29.37 (2CH2), 29.48 (CH2), 29.72 (7CH2), 31.92
(C7), 31.94 (C10), 35.04 (C30), 54.82 (C2), 64.78 (C1), 69.95 (C20),
71.63 (C4), 74.46 (C3), 129.10 (C9), 129.48 (C8), 176.71 (C10).
Cerebrosides (5). Brown solid, mp: 190–192 C, IR (KBr) νmax cm1:
3260, 2980, 2875, 1625, 1540, 1490, 1400, 1100, 1080, 740. HRMS-ESI
(positive ionization mode) m/z: 872.7200 [M þ H]þ, 844.6866 [M þ
H]þ, 759.6281 [M]þ, 810.6047 [M-OH]þ, 884.6484 [M þ H]þ. UHPLC-
QToF-MS m/z: 871.7200 [M]þ (C50H97NO10, calc. 871.7112), 843.6866
[M]þ (C48H93NO10, calc. 843.6799), 759.6281 [M]þ (C42H81NO10, calc.
759.5860), 827.6047 [M]þ (C47H89NO10, calc. 827.6486), 883.6487
[M]þ (C51H97NO10, calc. 883.7112). 1H NMR (400 MHz, DMSO-d6) δ
(ppm): 0.86 (t, J¼ 6.62 Hz, CH3), 1.24 (CH2), 1.48 (m, H-30), 1.50 (m, H-
5), 1.96 (m, H-7, H-10), 2.93 (ddd, J¼ 8.28 Hz, J¼ 8.5 Hz, J¼ 12.10 Hz,3H-20 0), 3.33 (m, H-4), 3.09 (m, H-40 0, H-50 0, H-30 0), 3.43 (m, H-60 0β, H-3),
3.66 (m, H-60 0α, H-1β), 3.83 (m, H-1α, H-20), 4.10 (m, H-2), 4.14 (d, J ¼
7.84 Hz, H-10 0), 4.36 (t, J ¼ 6.46 Hz, OH), 4.54 (t, J ¼ 5.5 Hz, OH), 4.79
(m, OH), 4.96 (m, OH), 5.32 (m, H-8, H-9), 5.60 (d, J ¼ 5.12 Hz, OH),
7.55 (d, J¼ 9.4 Hz, N–H). 13C NMR (100 MHz, DMSO-d6) δ (ppm): 14.41
(CH3), 22.57 (CH2), 24.85 (CH2), 24.90 (CH2), 26.10 (CH2), 27.14 (C7),
27.43 (C10), 29.08 (CH2), 29.17 (CH2), 29.20 (CH2), 29.46 (CH2), 29.49
(CH2), 29.54 (CH2), 29.57 (CH2), 29.66 (CH2), 31.77 (CH2), 32.52 (C5),
34.81 (C30), 50.34 (C2), 61.51 (C60 0), 69.42 (C1), 70.46 (C40 0), 71.01
(C4), 71.39 (C20), 73.92 (C20 0),74.64 (C3), 76.97 (C50 0), 77.36 (C30 0),
103.96 (C10 0), 129.84 (C9), 130.18 (C8), 174.25 (C10).
2.4. Methanolysis of (5)
Amixture of 5.0 mL of 1N HCl, 15 mL of MeOH, and 15 mg of (5)was
refluxed for 4 h (N2 atmosphere) withmagnetic stirring.Water was added
to the mixture. Furthermore, the solution was extracted with hexane.
After drying with anhydrous Na2SO4, the hexane extract was purified by
silica gel column chromatography eluted with CHCl3/Acetone (98:2) to
afford 5a (5.6 mg) (Figure 1). 5a was further analyzed by GC-MS: Peak 1
(tR 14.01 min, methyl 2-hydroxyoctadecanoate), EI-MS m/z: 314 [M]þ,
298, 281, 267, 255, 207, 74, 55, 43, 32; Peak 2 (tR 15.18 min, methyl 2-
hydroxytricos-9-enoate), EI-MS m/z: 382 [M]þ, 341 [M – (CH3)–(CH ¼
CH)]þ, 282 [341–CH3OCO]þ, 57, 41, 32; Peak 3 (tR 16.28 min, methyl 2-
hydroxytetracosanoate), EI-MS m/z: 398 [M]þ, 355 [M–(CH3)–(CH2)2]þ,
341 [355– (CH2)]þ, 327 [341–(OH)]þ, 283 [327–COO]þ, 57, 43; Peak 4
(tR 16.29 min, 2-methyl hydroxyhexacosanoate), EI-MS m/z 426 [M]þ,
268 [M– (CH3COO)–(CH3)–(CH2)6]þ, 250 [M–OH]þ, 82, 68, 55, 43; Peak
5 (tR 16.797 min, methyl 2-hydroxyheptacos-9-enoate), EI-MS m/z: 438
[M]þ, 355 [438–(CH3)–(CH2)3–(CH ¼ CH)]þ, 341 [355–(CH2)]þ, 326
[341– (CH3)]þ, 281 [326–COOH]þ, 82, 57, 43.
The aqueous MeOH layer was neutralized with NH4OH and extracted
with EtOAc. The EtOAc extract was concentrated to dryness and further
purified by a Sephadex LH-20 column eluted by CHCl3/MeOH (1:1) to
provide a Long-Chain Base (LCB) 5b (2.5 mg). The aqueous MeOH layer
was then concentrated to dryness and purified on silica gel column
(CHCl3/MeOH/H2O, 7:3:0.5) to give 3.0 mg of the methyl glucopyr-
anoside (5c) (Figure 1).
2.4.1. Acetylation of 5b
The mixture of acetic anhydride (Ac2O) (0.7 mL), pyridine (0.3 mL),
and 5b (2.5 mg) was allowed to stand at room temperature for 24 h, then
diluted with 10 mL of EtOAc and extracted with H2O (3  10 mL). The
organic phase was purified by a Sephadex LH-20 column (CHCl3/MeOH
1:1) giving the acetylated derivate (1.5 mg), this was analyzed by
UHPLC-QToF-MS. The chromatogram revealed a peak at tR 0.369 min:
m/z 442.2977 [M þ H]þ. HRMS-ESI: m/z 441.2977 [M]þ (C24H43NO6
calc. 441.3090), which corresponds to acetylated LCB.
2.5. Acetylation of isolated natural compounds
The acetylation reactions followed the same scheme used previously
to natural products (McCarthy et al., 2005). As consequence, it was
synthetized the corresponding acetylated derivates for (1), (2), (3), (4),
and (5).
2-(20-acetoxidecanoyl amino)-1,3,4-hexadecanotriacetat-8-ene (1Ac),
colorless resin. 1H NMR (400 MHz, CDCl3) δ (ppm): 0.88 (t, J ¼ 6.44 Hz,
6H, CH3), 1.25 (brs, CH2), 1.67 (m, 4H, H-5, H-6), 1.82 (m, 2H, H-30),
1.95 (m, 2H, H-7), 2.03 (s, 3H, CH3CO-1), 2.06 (s, 3H, CH3CO-4), 2.09 (s,
3H, CH3CO-3), 2.18 (s, 3H, CH3CO-20), 4.01 (dd, J ¼ 11.72 Hz, 2.12 Hz,
1H, H-1β), 4.36 (dd, J¼ 11.52 Hz, 6.18 Hz, 1H, H-1α), 4.45 (m, 1H, H-2),
4.95 (d, J¼ 9.72 Hz, 1H, H-4), 5.10 (m, 2H, H- 20, H-3), 5.37 (m, 2H, H-8,
H-9), 6.60 (d, J¼ 9.04 Hz, 1H, NH). 13C NMR (100 MHz, CDCl3) δ (ppm):
14.13 (CH3), 20.70 (CH3CO-1), 20.76 (CH3CO-4), 20.89 (CH3CO-3),
21.04 (CH3CO-20), 22.71 (CH2), 24.91 (CH2), 25.53 (CH2), 28.61 (C5),
29.25 (CH2), 29.38 (CH2), 29.45 (CH2), 29.57 (CH2), 29.60 (CH2), 29.63
Figure 1. Scheme for the methanolysis of (5).
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32.62 (C7), 47.86 (C2), 62.35 (C1), 72.30 (C-20), 74.02 (C3), 72.70 (C4),
129.29 (C9), 131.20 (C8), 170.04 (C10), 170.90 (CH3CO- 4), 170.98
(CH3CO-1), 171.31 (CH3CO-20, CH3CO-3).
Acetylated cerebrosides (5Ac). 1H NMR (400 MHz, CDCl3) δ (ppm):
0.90 (t, J ¼ 6.62 Hz, Me), 1.27 (brs, CH2), 1.62 (m, H-10), 1.85 (m, H-30,
H-5), 1.97 (m, H-7), 2.01 (s, CH3CO-4), 2.04 (s, CH3CO-3), 2.06 (s,
CH3CO-60 0, 40 0), 2.08 (s, CH3CO-30 0), 2.11 (s, CH3CO-20 0), 2.25 (s, CH3CO-
20), 3.71 (m, H-40 0, H-60 0β), 3.88 (d, J¼ 9.8 Hz, H-60 0α), 4.14 (d, J¼ 11.12
Hz, H-1β), 4.27 (m, H-2, H-1α), 4.49 (d, J ¼ 8.0 Hz, H-10 0), 4.91 (m, H-4,
H-20 0), 5.15 (m, H-50 0, H-3, H-20, H-30 0), 5.36 (m, H-8, H-9), 6.79 (d, J ¼
8.76 Hz, N–H). 13C NMR (100 MHz, CDCl3) δ (ppm): 14.13 (CH3), 20.55
(CH3CO-60 0), 20.59 (CH3CO-30 0), 20.68 (CH3CO-20 0), 20.72 (CH3CO-40 0),
20.94 (CH3CO-3), 21.01 (CH3CO-4), 21.03 (CH3CO-20), 22.70 (CH2),
24.90 (CH2), 24.92 (CH2), 25.75 (CH2), 26.88 (CH2), 27.29 (C10), 27.85,
27.95 (C17), 29.26 (CH2) 29.29 (CH2), 29.37 (CH2), 29.49 (CH2), 29.56
(CH2), 29.62 (CH2), 29.67 (CH2), 29.72 (CH2), 31.77 (CH2), 31.92 (C5),
31.93 (C30), 48.27 (C2), 61.76 (C1), 66.69 (C60 0), 68.12 (C50 0), 71.26
(C20), 71.66 (C30 0), 71.91 (C40 0), 72.75 (C20 0), 73.19 (C4), 73.98 (C3),
100.44 (C10 0), 128.77 (C9), 130.68 (C8), 169.31(C10), 169.39 (CH3CO-
30 0), 169.80 (CH3CO-20 0), 169.98 (CH3CO-60 0), 170.23 (CH3CO-40 0),
170.31 (CH3CO-4), 170.64 (CH3CO-3), 171.11 (CH3CO-20).
2.6. Biological assays
For antibacterial activity, double-distilled water, dimethyl sulfoxide
(DMSO) (JT Baker, USA), INC-80 incubator (Prendo), sterile 96-well
round-bottom microplates with lid (Corning Costar, New York), and
Mueller Hinton medium were used (Becton Dickinson). Strains of drug-
resistant clinical isolates were obtained from the University Hospital
Dr. Eleuterio Gonzalez of the Universidad Autonoma de Nuevo Leon.
Four of these bacteria are included in the list of priority pathogens issued
by the WHO, 2017. For cytotoxic activity, the cell lines tested were ob-
tained from ATCC (American Type Culture Collection, Manassas, VA,
USA), RPMI-1640 medium (Sigma Aldrich, St. Louis, MO, USA), DMEM
(Invitrogen, Thermo Fisher Scientific, Inc., Waltham, MA, USA) and fetal
bovine serum (SFB, Invitrogen), Cell Titer 96® aqueous solution cell
proliferation assay kit (Promega, Madison, WI, USA), automated ELISA
reader.
2.6.1. Antibacterial activity
Gram-positive bacteria tested: Methicillin-Resistant Staphylococcus
aureus (14–2095), Linezolid-resistant Staphylococcus epidermidis (14–583),
Vancomycin-resistant Enterococcus faecium (10–984). Gram-negative bac-
teria: Carbapenems-resistant Acinetobacter baumannii (12–666), Escherichia
coli producing extended-spectrum beta-lactamase (14–2081), P. aeruginosa
resistant to carbapenems (13–1391), carbapenems-resistant Klebsiella4pneumoniae NDM-1þ (14–3335), Klebsiella pneumoniae producer of ESBL
(14–2081) and carbapenems-resistant Klebsiella pneumoniae (OXA-48
positive). Only compounds (2), (3), (4), (5) and their acetylated derivates
were tested, compound (1) was obtained in small quantity thus it was not
tested. The antibacterial activity was developed by microdilution method
previously reported by Zgoda and Porter (2001). The range of concentra-
tions for the compounds was: 200, 100, 50, 25, 12.5, 6.25, and 3.12
μg/mL. Levofloxacin was used as positive control with the same concen-
trations, while DMSO (6%–0.09%, v/v) was the negative control. The
Minimum Inhibitory Concentration (MIC) was determined as the Mini-
mum Concentration of the compound that inhibits the growth of the
bacteria. The experiments were repeated three times.
2.6.2. Cytotoxic activity
The compounds were evaluated for their cytotoxic activity in human
cancer cells: PC3 (prostate), Hep3B and HepG2 (hepatocellular), MCF7
(breast), A549 (lung) and HeLa (cervical). In addition, a cell line of
immortalized human hepatocytes (IHH) was included as a control of non-
cancerous cells. PC3 cells were cultured in RPMI-1640 medium, while
Hep3B, HepG2, IHH, MCF7, A549 and HeLa in DMEM and supplemented
with fetal bovine serum 10% and with 2 mM glutamine. All cultures were
incubated at 37 C in a 5%CO2 atmosphere (Basu et al., 2006). The amount
of viable cells without proliferation was determined using the Cell Titer
96® proliferation kit, following the manufacturer's instructions (Promega,
Madison, WI, USA). Cell viability was determined by absorbance at 450
nm using an automated ELISA reader. The concentrations used were 100,
10, 1, 0.1, and 0.01 μg/mL to obtain a dose/response curve. The experi-
ments were performed in triplicate in three independent experiments.
Paclitaxel was used as reference. The data were analyzed in the Prism 5.0
statistical program. IC50 values were determined by regression analysis.
Selectivity Index was determined only against the hepatocellular
carcinoma lines. This allowed determining the selectivity of the cytotoxic
activity in them. SI was calculated as followed (Badisa et al., 2009):
SI¼ IC50 IHH cell
IC50 cancer cell
3. Results
3.1. Structure elucidation
Phytochemical investigation of CHCl3/MeOH extract of C. incisa
resulted in the isolation of a new ceramide (1), new cerebrosides within
the genus (5), of which (5-IV) and (5-V) are reported for the first time,
and three known compounds: 2,3-dihydroxypropyl tetracosanoate (2)
(Hernandez-Galicia et al., 2007), β-sitosterol-D-glucopyranoside (3)
(Njinga et al., 2016), and α-amyrin-3-O-β-D-glucopyranoside (4) (Kang
Figure 3. Fragmentation patterns of (1) that justify ions obtained in the EI-
MS spectrum.
D. Nocedo-Mena et al. Heliyon 6 (2020) e04671et al., 2011) (Figure 2). These compounds were identified by their
spectroscopic data and by comparing with those reported above, as well
that their acetylated derivates (Peshin and Kar, 2017).
2-(20-hydroxydecanoyl amino)-1,3,4-hexadecanotriol-8-ene (1) was
obtained as a white powder. The molecular formula of C26H51NO5 was
deduced from HRMS-ESI (positive ion mode) which showed the molec-
ular ion peak atm/z 475.3250 [Mþ H2O]þ. The 1H and 13C NMR spectra
of (1) gave signals characteristics of two long chain aliphatic moieties
consistent of methylenes (δH 1.28, brs, 22H; 1.62, m, 6H; δC 22.70–29.72)
and two terminal methyls (δH 0.90, t, J ¼ 6.66 Hz; δC 14.13) linked
through a secondary amide linkage (δH 7.02, m; δC 176.71), proposing
the structure of a natural ceramide. This was further supported by GC-MS
analysis yielding a peak at tR ¼ 105.92 min, corresponding to m/z 405
[M-3OH]þ. The EI-MS spectra of (1) allowed to identify a LCB and a
α-hydroxylated Long-Chain Fatty Acid (LCFA). The 1,3,4 trihydroxylated
LCB was confirmed by the ion m/z 287 (C16H33NO3), while the m/z 171
(C10H19O2) corresponded to the LCFA (Figure 3). Additionally, 1H NMR
also revealed the presence of δH 5.42 olefinic protons attributable to a
double bond, supported by two ethylenic carbons at δC 129.10 and δC
129.48. The position of the double bond was set at C8–C9 according to
Michaelson et al. (2016) criteria. The confirmation was found in the
EI-MS spectra by the fragments m/z 161 (C7H15NO3) and 187
(C9H17NO3) resulting from the rupture of the LCB on both sides of the
double bond (Figure 3). The double bond was determined to be trans,
according to the chemical shifts of the allyl carbons: δC 31.94 (C7) and δC
31.92 (C10). The chemical shifts of (1) were compared with the data
already reported of natural sphingolipids (Tapondjou et al., 2005) and
synthetic (Sugiyama et al., 1991), finding similarities that confirms (1) is
a ceramide. The elucidation of the structural skeleton was completed
based on the above comparison. Until our knowledge, there is no evi-
dence in the literature of this ceramide, being this study the first report of
its isolation and characterization.
The four hydroxyl groups of (1) were confirmed by means of acetyla-
tion and by the 1H and 13C NMR spectra of their corresponding tetraacetyl
derivative: 2-(20-acetoxidecanoyl amino)-1,3,4-hexadecanotriacetat-8-ene
(1Ac). Four singlets of acetyl groups were observed in δH (ppm): 2.03Figure 2. Chemical stru
5(CH3CO-1), 2.06 (CH3CO-4), 2.09 (CH3CO-3), 2.18 (CH3CO-20). Four
methyls attached to the ester carbonyl group in δC (ppm): 20.70 (CH3CO-
1), 20.76 (CH3CO-4), 20.89 (CH3CO-3), 21.04 (CH3CO-20), and four ester
carbonyls in δC (ppm): 170.90 (CH3CO- 4), 170.98 (CH3CO-1), 171.31
(CH3CO-20, CH3CO-3).
1H NMR showed the signals indicative of ceramides: a high field
signal corresponding to the terminal methyl (δH 0.88), then a broad
signal corresponding to the long aliphatic chains (δH 1.25), a methine
bound to nitrogen (δH 4.45). Finally, the proton of the secondary amide at
6.60 ppm (J ¼ 9.04 Hz) supported by the signal of its carbonyl at 170.04
(C10). Additionally, in the region between δH 4.0 and 5.1 ppm, appeared
the geminal hydrogens to the ester groups (H-1β, H-1α, H-2 0, H-3, H-4).
The double bond was located at position C-8 of the LCB because of
biogenetic considerations (Michaelson et al., 2016) and is supported by
the COSY correlation between H-7/H-8 (δH 1.95/δH 5.37) and HMBC
correlation between H-7/C9 (δH 1.95/δC 129.29). The geometry of this
bond was determined to be trans, according to the chemical shifts of the
adjacent carbons. Being reported in the literature that (E) isomers appear
around 32 ppm, while the (Z) at 27 ppm (Lü et al., 2008). The presence of
a 1,3,4-triacetylated LCB was deduced from COSY data: δH 6.60 (NH),
gave a crossed peak with the signal at δH 4.45 (H-2). Which, in turn,ctures of (1) to (5).
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4.01 and with H-3 (δH 5.10). The latter was correlated with the signal at
δH 4.95 (H-4). Binding of LCB to fatty acid was confirmed by the HMBC
correlation between H-1α and C10 (δH 4.36 and δC 170.04) (Figure 4). The
comparison of the chemical shifts of (1Ac)was similar to those of another
previously described acetylated sphingolipid (Lin et al., 2004).
Cerebrosides (5) were analyzed by UHPLC-QToF-MS. The chromato-
gram showed a series of peaks at different tR indicating the presence of a
mixture of homologous compounds. The abundance percentages ac-
cording to the chromatogram were: 30% (5-I, tR 0.34 min); 8% (5-II, tR
0.78 min); 46% (5-III, tR 1.61 min); 10% (5-IV, tR 4.21 min); and 6% (5-
V, tR 7.19 min). Thus, the HRMS-ESI (positive ionization mode) showed
peaks at: m/z 872 [M þ H]þ, 844 [M þ H]þ, 759 [M]þ, 810 [M-OH]þ,
and 883 [M]þ. The IR absorption band at 3260 cm1 and 1080 cm1
indicated the existence of hydroxyl and amide groups. The typical IR
absorptions at 1625 cm1 and 1540 cm1 suggested (5) was a secondary
amide derivative, which was supported by the presence of a nitrogen-
attached proton at δH 7.55 (d, J ¼ 9.4 Hz), a nitrogen-attached carbon
at δC 50.34 and a carbonyl carbon at δC 174.25 in the 1H and 13C NMR
spectra. Olefinic protons at δH 5.32 (H-8 and H-9) and olefinic carbons at
δC 130.18 and 129.84 were attributable to a double bond. The 1H spectra
also showed the presence of multiple proton signals between δH
1.25–1.96 and a triplet proton signal at δH 0.86 (J ¼ 6.62 Hz), suggesting
the presence of long-aliphatic chains. A sugar moiety could be distin-
guished in the structure of (5), which indicated by an anomeric proton
signal at δH 4.14 and an anomeric carbon signal at δC 103.96 in the 1H
and 13C spectra. A comparison of the spectroscopic data of (5)with those
of cerebroside (Lü et al., 2008) indicated that (5) is a cerebroside
analogue.
Methanolysis (Zhang et al., 2007) of (5) yielded a mixture of Fatty
Acid Methyl Esters (FAME) (5a), a trihydroxy LCB (5b), and a methyl
glucopyranoside (5c) (Figure 1). 5a were identified by GC-MS as methyl
2-hydroxyoctadecanoate, methyl 2-hydroxytricos-9-enoate, methyl
2-hydroxytetracosanoate, 2-methyl hydroxyhexacosanoate, methyl
2-hydroxyheptacos-9-enoate. In order to establish the structure of the
LCB, 5b was acetylated with Ac2O and pyridine. This was subjected to
UHPLC-QToF-MS analysis. The HRMS-ESI spectra of the peak at tR 0.369
min showed characteristic fragments at m/z 302, 178, 138 and 96
which indicated the structure of derivate should be 1,3,
4-triacetoxy-2-aminooctadec-8-ene.
The position of the double bond in the LCB was determined based on
the biogenetic origin (Michaelson et al., 2016). The above is supported
by the m/z 153 ion in HRMS-ESI spectra of (5), and by the strong COSY
correlation observed between protons H-7/H-10 (δ 1.96) with H-8/H-9 (δ
5.32). Similarly, the HMBC correlations between H-7/H-10 with C9/C8
confirmed this position in the LCB. The double bond was determined to
be Z geometry by its adjacent carbon signals at δ 27.14 (C7) and 27.43
(C10) (Inagaki et al., 1998). These correlations are shown in Figure 4.
An anomeric proton at δH 4.14 and six oxygenated carbon atoms at δC
103.96, 73.92, 77.36, 70.46, 76.97, 61.51 supported the presence of aFigure 4. Key 1H–1H COSY, HMBC and
6glucopyranoside. This was confirmed analyzing by HRMS-ESI (negative
mode) the methylated glucose obtained from the methanolysis of (5).
The presence of m/z 194 [M]- fully justified the methylglucopyranoside.
It is confirmed that the monosaccharide is glucose by the coupling con-
stants J4-5 ¼ 8.64 Hz and J4-3 ¼ 9.04 Hz, evidencing the axial-axial
coupling for H-40 0. The β configuration was also corroborated by J ¼
7.84 Hz of the anomeric proton, consistent with the expected axial-axial
coupling for the β-glucose anomer.
The linkage of the three parts of (5) was determined by the NOESY
experiment (Figure 4). In this, the proton signal of the δH 7.55 amide was
correlated with the protons H-20 (δH 3.83) of the long-chain fatty acid
part, as well as with H-1β (δ 3.66) and H-2 (δ 4.10) of the LCB.
Furthermore, the correlation between the H-1α/1β signals (δ 3.83/δ
3.66) of the LCB and the anomeric proton signal at δ 4.14 was also
observed. Therefore, (5) was determined as the mixture of five cere-
brosides: 1-O-β-glucopyranosyl-2-(20-hydroxyhexacosanoyl amino)-
1,3,4-octadecanetriol-8-ene (5-I); 1-O-β-glucopyranosyl-2-(20-hydrox-
ytetracosanoyl amino)-1,3,4-octadecanetriol-8-ene (5-II); 1-O-β-gluco-
pyranosyl-2-(20-hydroxyoctadecanoyl amino)-1,3,4-octadecanetriol-8-
ene (5-III); 1-O-β-glucopyranosyl-2-(20-hydroxytricos-9-enoyl amino)-
1,3,4-octadecanetriol-8-ene (5-IV); 1-O-β-glucopyranosyl-2-(20-hydrox-
yheptacos-9-enoyl amino)-1,3,4-octadecanetriol-8-ene (5-V) (Figure 2).
As far as we know, it is the first characterization of (5-IV) and (5-V) in the
literature. Additionally, it is the first report of all these cerebrosides (5)
within the genus Cissus.
The presence of four hydroxyl groups was confirmed by means of
acetylation of (5). The acetylated derivative (5Ac) was analyzed using
1D and 2D NMR techniques. As a result of acetylation reaction, the
singlet corresponding to the seven acetyl appeared as new signals in 1H
NMR, at δH: 2.01 (CH3CO-4), 2.04 (CH3CO-3), 2.06 (CH3CO-60 0, 40 0),
2.08 (CH3CO-30 0), 2.11 (CH3CO-20 0), and 2.25 (CH3CO-20). These signals
are supported by their respective carbons in the 13C spectra, δC: 20.55
(CH3CO-60 0), 20.59 (CH3CO-30 0), 20.68 (CH3CO-20 0), 20.72 (CH3CO-40 0),
20.94 (CH3CO-3), 21.01 (CH3CO-4), and 21.03 (CH3CO-20). Finally, the
carbons corresponding to carbonyls of the esters were observed between
δC 169.39 and 171.11. Above signals confirmed the presence of the seven
hydroxyls in the natural product. The position of the double bond in the
LCB was determined by HRMS-ESI in the natural product. Correlations
between H-8 and H-9 with C10 and C7 respectively, were observed in
the HMBC of the (5Ac). The cis configuration of the double bond was
evidenced in the natural product and also in its acetylated derivative by
chemical shifts of the carbons neighboring the double bond [δ 27.95
(C7), δ 27.29 (C10)]. The comparison of spectroscopic data of (5Ac)with
a similar sphingolipid derivative (Lin et al., 2004) allowed us to verify
the assignments.
3.2. Antibacterial activity
The results for the antibacterial activity of the compounds and their
acetylated derivates are shown in Table 1. Practically no antibacterialNOESY correlations of 1Ac and 5.
Table 1. Antibacterial activity of selected compounds isolated from C. incisa leaves.
Compoundsa Strains of MDR bacteriab. MIC (μg/mL)
MRSA LRSE VREF CRAB ECPB PARC KPNDM-1þ KPPB KPRO
(2) >200 200 200 200 >200 200 200 >200 200
(2Ac) >200 200 200 100 >200 200 200 >200 >200
(3) >200 200 200 200 >200 200 >200 >200 200
(3Ac) >200 >200 200 200 >200 200 >200 >200 200
(4) >200 >200 >200 >200 >200 100 >200 >200 >200
(5) >200 >200 >200 >200 >200 100 >200 >200 >200
(5Ac) >200 >200 >200 200 >200 200 200 200 200
levofloxacin 12.5 6.25 12.5 12.5 12.5 12.5 >50 >50 >50
a 2,3-dihydroxypropyl tetracosanoate (2); 3-(tetracosanoyloxy) propane-1,2-diyl diacetate (2Ac); β-sitosterol-D-glucopyranoside (3); β-sitosteryl β-D-tetraacetyl
glucopyranoside (3Ac); α-amyrin-3-O-β-D-glucopyranoside (4); cerebrosides (5); acetylated cerebrosides (5Ac).
b (MRSA) Methicillin-Resistant Staphylococcus aureus); (LRSE) Linezolid-resistant Staphylococcus epidermidis; (VREF) Vancomycin-resistant Enterococcus faecium;
(CRAB) Carbapenems-resistant Acinetobacter baumannii; (ECPB) Escherichia coli producing ESBL; (PARC) Pseudomonas aeruginosa resistant to carbapenems; (KPNDM-1þ)
carbapenems-resistant Klebsiella pneumoniae NDM-1þ; (KPPB) Klebsiella pneumoniae producer of ESBL; (KPOX) carbapenems-resistant Klebsiella pneumoniae (OXA 48-
positive).
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and (5) exhibited certain activity (MIC ¼ 100 μg/mL) against
P. aeruginosa resistant to carbapenems. According to literature, the
antibacterial activity of α-amyrin glucoside in P. aeruginosa has not been
reported yet, conversely to its aglycone α-amyrin which has shownMIC¼
1000 μg/mL on a Vernonia auriculifera screening (Kiplimo et al., 2011).
On the other hand, a cerebroside isolated from Spathodea campanulata
obtained MIC ¼ 12.5 μg/mL against ATCC strains of P. aeruginosa, out-
performing to our study carried out on MDR isolates (Mbosso et al.,
2008). However, a cerebrosides mixture from Euphorbia peplis was
inactive against ATCC strains of E. coli and S. aureus with MIC >160
μg/mL (Cateni et al., 2003), agreeing with the results obtained on same
strains. In a previous work, our research group reported the antibacterial
activity of the CHCl3/MeOH extract from C. incisa leaves (Nocedo-Mena
et al., 2020). Using the classification for the inhibitory activity for natural
extracts (Ndhlovu and Masika, 2017), the CHCl3/MeOH extract was
consider as a “strong inhibitor” of the bacterial growth. The most sensi-
tive strains were vancomycin-resistant Enterococcus faecium;
carbapenems-resistant Acinetobacter baumannii; and P. aeruginosa resis-
tant to carbapenems (MIC¼ 125 μg/mL for each one). Then, according to
the results here obtained, we can conclude that both compounds (4) and
(5) contribute to the antibacterial activity displayed in the corresponding
extract.
Regarding to the MIC values of the semi-synthetic derivatives, they
did not exceed to their natural products, except (2Ac) against
A. baumannii resistant to carbapenems (MIC ¼ 100 μg/mL). None of
natural product or derived were able to exceed the MIC value of the
positive control used.Table 2. Cytotoxic activity of selected compounds isolated from C. incisa leaves.
Compoundsa IC50 (μg/mL)
HepG2 SI Hep3B SI Hela SI
(2) 75  6 1.33 73  7 1.37 82  8 -
(3) ND - 55  5 1.82 ND -
(3Ac) 50  3 1.56 49  4 1.59 63  7 -
(4) >100 - >100 - >100 -
(4Ac) >100 - >100 - >100 -
(5) >100 - >100 - >100 -
Paclitaxel 64  103 1.24 33  103 2.41 4.78  103 -
a 2,3-dihydroxypropyl tetracosanoate (2); β-sitosterol-D-glucopyranoside (3); β-sito
(4); α-amyrin tetraacetyl 3-O-β-D-glucopyranoside (4Ac); cerebrosides (5).
73.3. Cytotoxic activity
According to the criteria of the National Cancer Institute of the USA, a
compound is considered active if it has an IC50  4 μg/mL on tumor cells
(Suffness and Pezzuto, 1990). According to the above, none of the
compounds evaluated classified with good anticancer activity. However,
β-sitosteryl β-D-tetraacetyl glucopyranoside (3Ac) was the most active
having IC50 values ¼ 43  4 μg/mL against the PC3 cancer line and 49.0
 4 μg/mL against Hep3B (Table 2).
The cytotoxic activity of CHCl3/MeOH extract in PC3 lines was pre-
viously determined by this research group (IC50 ¼ 57  4 μg/mL)
(Nocedo-Mena et al., Unpublished information). Analyzing the experi-
mental results obtained here, compound (3) practically no contributes to
the anticancer activity within the extract. Similar results were shown in a
previous study, in which El-Halawany et al. (2018) determined a
non-cytotoxic effect of (3) in lung cancer A-549, prostate cancer PC3 and
liver cancer HepG2 cells (IC50 > 100 μg/mL). However, in the current
study, its tetraacetylated derivative (3Ac) obtained the best results. It is
important to point out that, as far we know, there is no reported cytotoxic
activity for compound (3Ac) in any of the cancer lines tested.
The American Association for Cancer Research has suggested con-
ducting in vitro toxicity studies of a pharmacological regimen in the same
type cells to the cancer lines under study (Wilding and Bodmer, 2014).
This allows determining the selectivity of the treatment for the particular
type of cancer that is being studied. On this basis, in our study it was only
possible to determine the SI on the hepatocellular carcinoma lines.
It can appreciate in Table 2 the SI values reached are greater than 1.
That means that compounds (2), (3) and (3Ac) were more selective forPC3 SI MCF7 SI A549 SI IHH
75  5 - ND - >100 - 100
53  4 - ND - ND - 100
43  4 - - 87  8 - 78  7
>100 - >100 - >100 - >100
>100 - >100 - >100 - >100
>100 - >100 - >100 - >100
10.2  103 - 4.27  103 - 5.12  103 - 79.4  103
steryl β-D-tetraacetyl glucopyranoside (3Ac); α-amyrin-3-O-β-D-glucopyranoside
D. Nocedo-Mena et al. Heliyon 6 (2020) e04671tumor cells, even with their low cytotoxic effects. (3Ac) achieved better
IC50 and SI values on HepG2 and Hep3B cell lines, without exceeding
Paclitaxel.
4. Discussion
Several plants are used today in traditional medicine in the world,
without being scientifically validated. In the course of our investigations,
we previously have determined the therapeutic potential of the
extracts and some isolated compounds of C. incisa (Nocedo-Mena et al.,
Unpublished results). The current study leads to the isolation and char-
acterization of various compounds, among them, β-sitosterol-D-gluco-
pyranoside (3) and α-amyrin-3-O-β-D-glucopyranoside (4), have been
studied by other authors in relation to their antibacterial and cytotoxic
activities (Salama et al., 2012; Araújo et al., 2017; Nzogong et al., 2018).
Previous and current findings can be able to justify the use of this plant in
traditional Mexican medicine to treat certain ailments, infectious or
cancerous.
Cerebrosides (5-IV; 5-V) and the ceramide (1) isolated from this plant
are sphingolipids reported for the first time. Sphingolipids and their
derivatives are ubiquitous bio-active components of cells. They are
structural elements in the lipid bilayer and contribute to the dynamic
nature of the membrane.
Complex sphingolipids in plants are formed by a ceramide back-bone
comprised of a LCB esterified to a LCFA or to a very long chain (VLCFA).
Cerebrosides are glycosphingolipids consisting of a ceramide and a single
sugar residue at C-1. The sugar moiety is either glucose or galactose.
These amphipathic molecules, cerebrosides, have been reported to
exhibit a variety of biological effects on ulcer gastritis and tumors, im-
mune reinforcement, as well as inhibitory effect on angiogenesis in some
cancers (Lee et al., 2015; Michaelson et al., 2016). Ceramides have also
been tested as active metabolites. Over the past 30 years, ceramides have
been found to mediate biological processes as diverse as maintaining cell
membrane dynamics, fluidity, and internal transport through it.
Furthermore, they play a fundamental role in the regulation of cell
viability, senescence, differentiation, the cell cycle and the stress
response through a series of signaling cascades (Canals et al., 2018). In
addition, ceramides are associated with different pathological disorders
such as cancer, liver disease, diabetes, cardiovascular disease and lung
inflammation, which has sparked interest in the field of pharmaceutical
development, highlighting research related to antimicrobial (Bano et al.,
2019) and anticancer properties (Ryland et al., 2013; Morad et al., 2017).
Regarding to biological assays, only (4) and (5) showed antibacterial
activity (MIC ¼ 100 μg/mL) against P. aeruginosa resistant to carbape-
nems. The result for the amyrin-3-O-β-D-glucopyranoside (4) agrees with
Vazquez et al. (2012), who reported the antimicrobial activity of pen-
tacyclic triterpenes with MIC range of 64–1088 μg/mL against ATCC
strains of S. aureus, S. epidermidis, K. pneumoniae, E. coli, P. aeruginosa.
However, in relation to cerebrosides (5), our results did not accord with
those Cateni et al. (2003). In their case, the cerebrosides were inactive,
exhibiting MIC >200 μg/mL against ATCC strains of S. aureus and E. coli.
As can be appreciated in Table 1, in general sense, the acetylated
derivatives did not outperform their natural products in the antibacterial
action. For the sterol glucoside, this result agrees with that obtained by
Abreu et al. (2011), who concluded that the free hydroxyl group at po-
sition 3 could be related to the bactericidal activity of the compounds
tested. The results of the low antibacterial activity of the acetylated de-
rivatives of ceramides and cerebrosides are in accordance with those
reported by M€outs et al. (2018). In their study, these researchers refer to
the importance of the functional groups C-1 (OH) and C-3 (OH) of the
LCB for interlipid interaction and lateral segregation in ceramide-rich
domains, this being one of the mechanisms by which ceramides modify
the permeability of membranes. However, obtaining semi-synthetic8derivatives is a strategy used to improve multiple characteristics of nat-
ural antibiotics, such as: improving potency and spectrum, particularly
activity against resistant organisms; as well as reducing toxicity and other
undesirable effects (Brown and Dawson, 2015).
Concerning the tested strains, we found that the most sensitive was
PARC (MIC ¼ 100 μg/mL), while the most resistant was MRSA (MIC
>200 μg/mL). In a recently published study, the antibacterial activity
of ceramides isolated from C. incisa against CRAB reached MIC ¼ 50
μg/mL (Nocedo-Mena et al., 2020). All these results suggest that
C. incisa sphingolipids are active against Gram-negative species. The
fact that some phytocompounds of this plant are active in these bac-
teria makes them good candidates for developing novel antibacterials.
Further investigations could be made to evaluate the combination of
the above natural products with commercial antibacterials that
currently cannot be used to treat Gram-negative infections due to poor
accessibility by the cellular envelope of these bacteria. In this sense,
natural products and those optimized by synthesis or semisynthesis will
become the next generation of antibacterial agents (Brown and Daw-
son, 2015).
The findings related to the cytotoxic activity, revealed that compound
(3Ac) exhibited the best IC50 values against PC3 (43  4 μg/mL) and
Hep3B (49  4 μg/mL) cells. Previously, it has been determinate the
capacity of this natural product to perturbing the cell cycle and inducing
apoptotic cell death in cancer cells (Rajavel et al., 2017).
In relation to the selectivity on the hepatocellular carcinoma cell
lines, the SI values reached were more significant than 1.0, which makes
all assayed compounds more selective for tumor cells. This result is
consistent with the work of Shen et al. (2018), who obtained good scores
testing triterpenes and glycosides against a hepatocellular cancer line by
induction of apoptosis. The structure-activity relationship established for
these authors concluded that the hydroxyl or monosaccharide at position
C-3, make the compounds show better cytotoxic activity. The selectivity
obtained for Hep3B is interesting because, in this type of cancer, the p53
gene involved in apoptosis, is mutated. Several studies suggest that
phytosterols disrupt the cell cycle and induce apoptosis by activating
caspases 3 and 9 in cancer cells, suggesting their use for the treatment of
this cancer (Maiyo et al., 2016).
In a general sense, natural products have long been explored as
invaluable sources of inspiration for drug design, with particular effec-
tiveness in cancerous and infectious diseases (Rodrigues et al., 2016).
Other studies with natural products in the treatment of cancer have
shown synergistic effects of the combination with chemotherapeutic
agents (Zong et al., 2019).
5. Conclusions
Our study constitutes the first characterization of the ceramide 2-(20-
hydroxydecanoyl amino)-1,3,4-hexadecanotriol-8-ene (1), and cerebro-
sides (5-IV, 5-V). At the same time, compound (2) and all sphingolipids
obtained are reported for the first time within Cissus. Only α-amyrin-3-O-
β-D-glucopyranoside (4) and cerebrosides mixture (5) exhibited activity
(MIC ¼ 100 μg/mL) against P. aeruginosa resistant to carbapenems.
Meanwhile, β-sitosteryl β-D-tetraacetyl glucopyranoside (3Ac) was the
most active on PC3 (IC50 ¼ 43  4 μg/mL) and the most selective on
HepG2 and Hep3B cancer lines. The Selectivity Index reached on the
hepatocellular carcinoma lines, revealed potentialities of the compounds
to treat selectively this type of cancer.
This research reveals the importance of study medicinal plants from
the chemical and pharmacological point of view, to contribute to the
scientific knowledge, and as sources of potential drugs. The traditional
use of C. incisa leaves in traditional Mexican medicine is justified; how-
ever, other studies would be needed to confirm the safety and efficacy of
the plant. Further investigations could be made to assess the synergistic
D. Nocedo-Mena et al. Heliyon 6 (2020) e04671effects of combining the above natural products with chemotherapeutic
and antibacterial agents in the face of increased of these diseases.
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